Lopez-Albaitero; Andres

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lopez-Albaitero; Andres.The latest application filed is for "bispecific her2 and cd3 binding molecules".

Company Profile

5.6.8

Lopez-Albaitero; Andres - New York NY
Lopez-Albaitero; Andres - Pittsburgh PA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA Grant 11,168,150 - Cheung , et al. November 9, 2	2021-11-09
Bispecific Her2 And Cd3 Binding Molecules App 20210324079 - Cheung; Nai-Kong V. ; et al.	2021-10-21
Bispecific HER2 and CD3 binding molecules Grant 11,046,768 - Cheung , et al. June 29, 2	2021-06-29
Bispecific Her2 And Cd3 Binding Molecules App 20200199248 - CHEUNG; Nai-Kong V. ; et al.	2020-06-25
T Cell Receptor-like Antibody Agents Specific For Ebv Latent Membrane Protein 2a Peptide Presented By Human Hla App 20200115470 - Cheung; Nai-Kong V. ; et al.	2020-04-16
Bispecific HER2 and CD3 binding molecules Grant 10,519,248 - Cheung , et al. Dec	2019-12-31
T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA Grant 10,501,559 - Cheung , et al. Dec	2019-12-10
Bispecific Her2 And Cd3 Binding Molecules App 20190359732 - CHEUNG; Nai-Kong V. ; et al.	2019-11-28
Bispecific HER2 And CD3 Binding Molecules App 20180273623 - Cheung; Nai-Kong V. ; et al.	2018-09-27
T Cell Receptor-like Antibody Agents Specific For Ebv Latent Membrane Protein 2a Peptide Presented By Human Hla App 20180258187 - Cheung; Nai-Kong V. ; et al.	2018-09-13
Bispecific Her2 And Cd3 Binding Molecules App 20170210819 - CHEUNG; Nai-Kong V. ; et al.	2017-07-27
Cytotoxic T cell defined EGFR peptide and an optimized derivative peptide Grant 8,367,069 - Ferris , et al. February 5, 2	2013-02-05
Cytotoxic T Cell Defined Egfr Peptide And An Optimized Derivative Peptide App 20110171170 - Ferris; Robert L. ; et al.	2011-07-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.